BVF INC/IL - REVOLUTION MEDICINES INC ownership

REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 191 filers reported holding REVOLUTION MEDICINES INC in Q4 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.9%.

Quarter-by-quarter ownership
BVF INC/IL ownership history of REVOLUTION MEDICINES INC
ValueSharesWeighting
Q2 2024$232,130,838
+20.4%
5,981,2120.0%6.51%
+22.8%
Q1 2024$192,774,463
+12.4%
5,981,2120.0%5.30%
+23.5%
Q4 2023$171,541,160
+55.7%
5,981,212
+50.2%
4.29%
+44.4%
Q3 2023$110,199,948
-34.1%
3,981,212
-36.4%
2.97%
-36.3%
Q2 2023$167,336,979
+55.9%
6,255,588
+26.2%
4.66%
+18.9%
Q1 2023$107,338,036
+38.4%
4,955,588
+52.2%
3.92%
+19.9%
Q4 2022$77,548,106
+20.8%
3,255,5880.0%3.27%
+23.4%
Q3 2022$64,200,000
+46.0%
3,255,588
+44.3%
2.65%
+24.9%
Q2 2022$43,961,000
-4.8%
2,255,588
+24.6%
2.12%
+14.9%
Q1 2022$46,187,000
+1.3%
1,810,5490.0%1.85%
+11.7%
Q4 2021$45,572,000
-33.3%
1,810,549
-27.1%
1.65%
-38.0%
Q3 2021$68,364,000
-13.3%
2,485,0490.0%2.67%
-9.8%
Q2 2021$78,875,000
-41.6%
2,485,049
-15.6%
2.96%
-41.6%
Q1 2021$135,027,000
+23.2%
2,943,049
+6.3%
5.06%
+17.4%
Q4 2020$109,587,000
+49.9%
2,768,049
+31.7%
4.31%
+8.3%
Q3 2020$73,117,000
+190.1%
2,101,049
+163.2%
3.98%
+156.2%
Q2 2020$25,202,000
-17.7%
798,286
-42.9%
1.55%
-45.6%
Q1 2020$30,632,0001,398,0702.86%
Other shareholders
REVOLUTION MEDICINES INC shareholders Q4 2023
NameSharesValueWeighting ↓
TRV GP II, LLC 1,909,317$75,590,00052.65%
TRV GP III, LLC 7,024,031$278,081,00023.88%
Ponoi II Management, LLC 685,011$27,120,00019.76%
TRV GP IV, LLC 1,419,900$56,214,00018.03%
Ponoi Management, LLC 685,011$27,120,00015.52%
Column Group LLC 3,580,252$141,742,00012.86%
BVF INC/IL 2,768,049$109,587,0004.31%
Boxer Capital, LLC 3,309,264$131,014,0004.21%
Cormorant Asset Management, LP 2,495,066$98,780,0002.35%
Casdin Capital, LLC 1,634,535$64,711,0001.92%
View complete list of REVOLUTION MEDICINES INC shareholders